Cardiovascular DiseasesNCT06272318
Vital Signs Blood Pressure Trial
An observational study of Cardiovascular Diseases and Hypertension, run by Stanford University at 1 site in United States.
Trial summary
The purpose of this study is collect subject vitals with a blood pressure cuff, electrocardiogram (ECG), and photoplethysmogram (PPG). This data can then be used to develop a reliable, accurate, noninvasive, and continuous blood pressure monitoring device. Read more about this study
- Who is it for?
- Ages 18 to 64 yearsHealthy volunteers can take part
- Conditions the study is for
- Cardiovascular Diseases, Hypertension, Blood Pressure
- What is being tested?
- Blood Pressure Cuff, EKG, PPG
- How many people
- 50 participants
- Where
- 1 siteUnited States
- Study dates
- 4 May 2026to 30 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 64 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Participants with a range of health conditions are needed for this study, including those with cardiac or blood pressure issues, as well as individuals who are considered healthy.
Who may be able to join
- Age >17 and <65 years
- BMI >20 and <35
Who cannot join
- Age <18 or >64
- BMI <20 or >35
- Pregnancy
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is collect subject vitals with a blood pressure cuff, electrocardiogram (ECG), and photoplethysmogram (PPG). This data can then be used to develop a reliable, accurate, noninvasive, and continuous blood pressure monitoring device.
- Conditions
- Cardiovascular Diseases, Hypertension, Blood Pressure
- Being tested
- Blood Pressure Cuff, EKG, PPG
- Medical subject headings
- Cardiovascular Diseases, Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Blood Pressure Cuff, EKG, PPGOther
A blood pressure cuff, an EKG, and a PPG will be utilized to collect subject vitals.
What is being measured
The primary outcome is the main question the study is designed to answer.
Collection of Subject Name (optional)
Measured: Less than 1 minute
Collection of Subject Height
Height in meters
Measured: Less than 1 minute
Collection of Subject Weight
Weight in kilograms
Measured: Less than 1 minute
Collection of Subject Age
Age in years
Measured: Less than 1 minute
Collection of Subject Medical Comorbidities
Measured: 1 minute
Systolic and Diastolic Blood Pressure Measurement
Using blood pressure cuff; measured three times to find the initial, interim, and final blood pressure
Measured: 1-2 minutes
Collection of ECG Waveforms
Using an electrocardiogram (ECG) to measure heart rhythm
Measured: 5 minutes
Collection of PPG Waveforms
Using a photoplethysmography (PPG) to monitor heart rate
Measured: 5 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Feb 2024
- Study start4 May 2026
- Primary completion28 Aug 2026
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cardiovascular DiseasesStudies of the same condition, open and under way.
- More trials run by Stanford UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Stanford University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Alexandra Ruan, Stanford University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06272318
- Sponsor's protocol ID
- 74131
- Status last verified
- Sep 2026
- First submitted
- 6 Feb 2024
- Last updated
- 30 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Vital Signs Blood Pressure Trial
- ClinicalTrials.gov ID
- NCT06272318
- Acronym / sponsor ID
- 74131
- Conditions
- Cardiovascular Diseases, Hypertension, Blood Pressure
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Stanford UniversityUniversity, hospital or other
- Study start
- 4 May 2026 (actual)
- Primary completion
- 28 Aug 2026 (actual)
- Study completion
- 30 Dec 2026 (estimated)
- First posted
- 22 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is collect subject vitals with a blood pressure cuff, electrocardiogram (ECG), and photoplethysmogram (PPG). This data can then be used to develop a reliable, accurate, noninvasive, and continuous blood pressure monitoring device.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Participants with a range of health conditions are needed for this study, including those with cardiac or blood pressure issues, as well as individuals who are considered healthy.
Key inclusion criteria (2 listed)
- Age >17 and <65 years
- BMI >20 and <35
Key exclusion criteria (3 listed)
- Age <18 or >64
- BMI <20 or >35
- Pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Blood Pressure Cuff, EKG, PPGA blood pressure cuff, an EKG, and a PPG will be utilized to collect subject vitals. | Other | – |
Primary outcome
Collection of Subject Name (optional)
Time frame: Less than 1 minute
Collection of Subject Height
Time frame: Less than 1 minute
Height in meters
Collection of Subject Weight
Time frame: Less than 1 minute
Weight in kilograms
Collection of Subject Age
Time frame: Less than 1 minute
Age in years
Collection of Subject Medical Comorbidities
Time frame: 1 minute
Systolic and Diastolic Blood Pressure Measurement
Time frame: 1-2 minutes
Using blood pressure cuff; measured three times to find the initial, interim, and final blood pressure
Collection of ECG Waveforms
Time frame: 5 minutes
Using an electrocardiogram (ECG) to measure heart rhythm
Collection of PPG Waveforms
Time frame: 5 minutes
Using a photoplethysmography (PPG) to monitor heart rate
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2026.
Related trials for Cardiovascular Diseases
Active, not recruitingPhase 3
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
Ischemic Optic Neuropathy
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Not yet recruitingPhase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiovascular Diseases and Hypertension, run by Stanford University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Collection of Subject Name (optional) (time frame: Less than 1 minute). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.